• Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

Novo Nordisk’s Ozempic and Wegovy Reshape Denmark’s Economy

Novo Nordisk, the Danish company behind two popular obesity medications, is reaping huge profits and is now responsible for most of the country’s economic growth.

Eshe Nelson
Author: Eshe Nelson

Written by

Eshe Nelson

in

Denmark, Diabetes, Drugs (Pharmaceuticals), Economic Conditions and Trends, Gross Domestic Product, Novo Nordisk A/S, Ozempic (Drug), Semaglutide (Drug)
←Oliver Anthony Music’s ‘Rich Men North of Richmond’ Stays No. 1
France To Ban Muslim Students From Wearing Abayas In Schools→

More posts

  • How To Recover From Dry Winter Scalp

  • Iran War Causing Largest Ever Oil Disruption, I.E.A. Says

  • Uber, which exited self-driving in 2020, is now at the center of the robotaxi era

  • U.S. Trade Deficit Falls in January

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube